![Eton Pharmaceuticals, Inc. logo](/logos/ETON.webp)
Eton Pharmaceuticals, Inc.
NASDAQ:ETON
Overview | Financials
Company Name | Eton Pharmaceuticals, Inc. |
Symbol | ETON |
Currency | USD |
Price | 4.59 |
Market Cap | 118,588,158 |
Dividend Yield | 0% |
52-week-range | 3.03 - 5.81 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Sean E. Brynjelsen |
Website | https://www.etonpharma.com |
An error occurred while fetching data.
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD